Self-pay patients and the few who have coverage are depleting the supply, sometimes at the expense of those who need the meds for their diabetes
First identified in human plasma, GHK-Cu has been widely studied in laboratory research for its potential role in tissue repair, collagen synthesis, and cellular regeneration pathways
The Rising Challenge of DM2 and Obesity The global burden of DM2 presented a significant concern in 2019, with an estimated 9.3% prevalence, equating to 463 million individuals affected
That guidance concerns semaglutide within its cardiovascular risk-reduction indication and should not be confused with general NHS access to Wegovy tablets for weight management
Additionally, insulin exerts little impact on cardiovascular complications, a key contributor to morbidity and mortality in patients with diabetes (Zheng et al., 2018)
Behzad, H., Sharma, A., Mousavizadeh, R., Lu, A